Aclaris Therapeutics, Inc. - London Stock Exchange - US00461U1051

Aclaris Therapeutics, Inc. (US00461U1051)

|

3,38 USD

Stand (close): 25.02.26

Übersicht

Funtamental

Chart

Nachrichten (teilweise englisch)

KGV (PE)		Gewinn pro Aktie (unverwässert)	-1,36
KGV/Gewinnwachstum (PEG)		Gewinn pro Aktie (verwässert)	-1,36
Dividende pro Aktie		Gewinn pro Aktie Erwartung dieses Jahr
Dividendenrendite		Gewinn pro Aktie Erwartung nächstes Jahr
Umsatz pro Aktie	0,14	Gewinnmarge	%
Verschuldung pro Aktie		Buchwert pro Aktie	1,11
Cashflow pro Aktie		Kurs-Buchwert-Verh.	3,05
		⌀ Analystenschätzung

Angaben in USD und ohne Gewähr

Dividendenzahlungen
Titel	Ex-Datum	Zahldatum	Bruttobetrag

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

immer aktiv

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Dauer	Beschreibung
cookielawinfo-checkbox-advertisement	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.

Cookie	Dauer	Beschreibung
_ga	2 years	The _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
_ga_KW32SV2E94	2 years	This cookie is installed by Google Analytics.

Others

3,38 USD

Stand (close): 25.02.26

Angaben in USD und ohne Gewähr

Dividendenzahlungen

Benutzer

Neueste Beiträge